Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background  CLEC-2 is a platelet receptor with an important role in thromboinflammation but a minor role in hemostasis. Two endogenous ligands of CLEC-2 have been identified, the transmembrane protein podoplanin and iron-containing porphyrin hemin, which is formed following hemolysis from red blood cells. Other exogenous ligands such as rhodocytin have contributed to our understanding of the role of CLEC-2. Objectives  To identify novel CLEC-2 small-molecule ligands to aid therapeutic targeting of CLEC-2. Methods  ALPHA screen technology has been used for the development of a high-throughput screening (HTS) assay recapitulating the podoplanin-CLEC-2 interaction. Light transmission aggregometry was used to evaluate platelet aggregation. Immunoprecipitation and western blot were used to evaluate direct phosphorylation of CLEC-2 and downstream protein phosphorylation. Autodock vina software was used to predict the molecular binding site of katacine and mass spectrometry to determine the polymeric nature of the ligand. Results and Conclusion  We developed a CLEC-2-podoplanin interaction assay in a HTS format and screened 5,016 compounds from a European Union-open screen library. We identified katacine, a mixture of polymers of proanthocyanidins, as a novel ligand for CLEC-2 and showed that it induces platelet aggregation and CLEC-2 phosphorylation via Syk and Src kinases. Platelet aggregation induced by katacine is inhibited by the anti-CLEC-2 monoclonal antibody fragment AYP1 F(ab)′2. Katacine is a novel nonprotein ligand of CLEC-2 that could contribute to a better understanding of CLEC-2 activation in human platelets.

References Powered by Scopus

This article is free to access.

Get full text

This article is free to access.

Cited by Powered by Scopus

16Citations
46Readers
Get full text
2Citations
10Readers

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Morán, L. A., Di, Y., Sowa, M. A., Hermida-Nogueira, L., Barrachina, M. N., Martin, E., … García, Á. (2022). Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist. Thrombosis and Haemostasis, 122(8), 1361–1368. https://doi.org/10.1055/a-1772-1069

Readers over time

‘22‘23‘2401234

Readers' Seniority

Tooltip

Professor / Associate Prof. 3

50%

Researcher 2

33%

PhD / Post grad / Masters / Doc 1

17%

Readers' Discipline

Tooltip

Chemistry 2

40%

Agricultural and Biological Sciences 1

20%

Medicine and Dentistry 1

20%

Biochemistry, Genetics and Molecular Bi... 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0